California Agriculture Online
California Agriculture Home  >   Volume 54   >   Number 5  >   Viewing Expanded Abstract

peer-reviewed research article

Nutraceuticals: Separating the wheat from the chaff

authors

Andrea T. Borchers, Department of Nutrition
Carl L. Keen, Department of Nutrition
Judy S. Stern, Department of Nutrition
M. Eric Gershwin, Division of Rheumatology, Allergy and Clinical Immunology

publication information

California Agriculture 54(5):26-32. DOI: 10.3733/ca.v054n05p26. September-October 2000.

abstract

Foods provide nutrients such as vitamins, minerals, protein, carbohydrate and fat and a host of other nonessential nutrients that may confer health benefits. Some “nutraceuticals” have been found to boost the immune system, enhance memory function and possibly slow the aging process. For example, flavonoids — which are found in red wine, purple grape juice, green tea and cocoa products — exhibit potent antioxidant activity in laboratory experiments and have been postulated to protect against coronary artery disease and reduce the risk of cancer. Recognizing potential health benefits from flavonoids and other plant extracts, some manufacturers are creating “functional” foods by fortifying, bioengineering and otherwise modifying foods so that they contain higher than normal concentrations of these components. With the exception of echinacea, St. John's wort and Ginkgo biloba, there is a paucity of scientific data for the majority of botanicals sold in health food stores and supermarkets. At the same time, adverse reactions to some botanicals have been documented in humans. Many would argue that government regulation of botanicals is inadequate. Further studies and comprehensive databases are needed to establish the safety and efficacy of popular and widely consumed dietary supplements.

author affiliations

A.T. Borchers is Postdoctoral Fellow, Department of Nutrition, UC Davis; C.L. Keen is Chair and Professor, Department of Nutrition, UC Davis; J.S. Stern is Professor, Department of Nutrition, UC Davis; M.E. Gershwin is Chief and Professor, Division of Rheumatology, Allergy and Clinical Immunology, UC Davis.

References

Borchers AT, Keen CL, Hannum S, Gershwin ME. Cocoa and chocolate: Composition, bioavailability and health implications. J Med Food 2000.

Consumer Reports. Herbal roulette. 1995. 60(11):705.

Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990–1997: Results of a follow-up national survey. JAMA. 1998. 280:75. DOI: 10.1001/jama.280.18.1569 [CrossRef]

Eisenberg DM, Kessler RC, Foster C, et al. Unconventional medicine in the United States: Prevalence, costs and patterns of use. N Engl J Med. 1993. 328:52. DOI: 10.1056/NEJM199301283280406 [CrossRef]

[FDA] U.S. Food and Drug Administration. Dietary Supplement Health and Education Act of 1994 1994. Accessed October 2000 http://vm.cfsan.fda.gov/-dms/dietsupp.html

Hertog MGL, Feskens EJM, Hollman PCH, et al. Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen elderly study. Lancet. 1993. 342:11. DOI: 10.1016/0140-6736(93)92876-U [CrossRef]

Hertog MGL, Kromhout D, Aravanis C, et al. Flavonoid intake and long-term risk of coronary disease and cancer in the seven countries study. Arch Intern Med. 1995. 155:6. DOI: 10.1001/archinte.155.4.381 [CrossRef]

Institute of Medicine, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium and Carotenoids 2000. Washington DC:National Academy Press.

Kanowski S, Herrmann WM, Stephan K, et al. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Pharmacopsychiatry. 1996. 29:56.

Kleijnen J, Knipschild P. Ginkgo biloba for cerebral insufficiency. Br J Clin Pharmacol. 1992. 34:8.

Knekt P, Jarvinen R, Reunanen A, Maatela J. Flavonoid intake and coronary mortality in Finland: A cohort study. Brit Med J. 1996. 312:81.

Kondo K, Hirano R, Matsumoto A, et al. Inhibition of LDL oxidation by cocoa. Lancet. 1996. 348: DOI: 10.1016/S0140-6736(05)65927-2 [CrossRef]

Kruger RM. The herb garden grows. Discount Merchandiser. 1998. 1998:7.

Laakmann G, Schule C, Baghai T, Kieser M. St Johna's wort in mild to moderate depression: The relevance of hyperforin for the clinical efficacy. Pharmacopsychiatry. 1998. 31(Suppl 1):9.

Le Bars PL, Katz MM, Berman N, et al. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. JAMA. 1997. 278:32. DOI: 10.1001/jama.278.16.1327 [CrossRef]

Lenoir S, Degenring FH, Sailer R. A double-blind randomised trial to investigate three different concentrations of a standardised fresh plant extract obtained from the shoot tips of Hypericum perforatum. L Phytomedicine. 1999. 6:6.

Lotito SB, Fraga CG. (+)-Catechin prevents human plasma oxidation. Free Rad Biol Med. 1998. 24:41. DOI: 10.1016/S0891-5849(97)00276-1 [CrossRef]

Melchart D, Walther E, Linde K, et al. Echinacea root extracts for the prevention of upper respiratory tract infections. Arch Fam Med. 1998. 7:5. DOI: 10.1001/archfami.7.6.541 [CrossRef]

Mizuno M, Yamada J, Terai H, et al. Differences in the immunomodulating effects between wild and cultured Panax ginseng.. Biochem Biophys Res Commun. 1994. 200:8. DOI: 10.1006/bbrc.1994.1644 [CrossRef]

Piscitelli SC, Burstein AH, Chaitt D, et al. Indinavir concentrations and St. John's wort. Lancet. 2000. 355:8. DOI: 10.1016/S0140-6736(99)05712-8 [CrossRef]

Potter JD, Steinmetz K. Stewart BW, McGregor D, Kleihues P. Vegetables, fruit and phytoestrogens as preventive agents. Principles of Chemo-prevention 1996. Lyon, France:IARC Scientific Publications. p61p. 90.

Radice C. Herbal poll. Progressive Grocer 1998. (May)p.141.

Rein D, Paglieroni TG, Wun T, et al. Cocoa inhibits platelet activation and function. Am J Clin Nutr. 2000. 72:5.

Ruschitzka R, Meier PJ, Turina M, et al. Acute heart transplant rejection due to St. John's wort. Lancet. 2000. 355:9. DOI: 10.1016/S0140-6736(99)05467-7 [CrossRef]

Scimone A, Scimone A. U.S. sees the green in herbal supplements. Chemical Market Reporter 1998. Jul13pp.FR3-4.

Stanley LL, Mazier MJP. Potential explanations for the French paradox. Nutr Res. 1999. 19:15. DOI: 10.1016/S0271-5317(98)00167-5 [CrossRef]

Terao J, Piskula M, Yao Q. Protective effect of epicatechin, epicatechin gallate and quercetin on lipid peroxidation in phospholipid bilayers. Arch Biochem Biophys. 1994. 308:84. DOI: 10.1006/abbi.1994.1039 [CrossRef]

Wheatley D. LI 160, an extract of St. John's wort, versus amitriptyline in mildly to moderately depressed outpatients: A controlled 6-week clinical trial. Pharmacopsychiatry. 1997. 30(Suppl 2):80.

Wilhelm C. Growing pains in botanicals and herbal supplements. Chemical Market Reporter 1999. Nov8pp.FR12-3.

Williamson JS, Wyandt CM. The herbal generation: Legal and regulatory considerations. Drug Topics 1999. Apr19pp.101-10.


  • Search Article Text 1946 to Present
Advanced Search